Clinical Trial Update: Study Of Celecoxib Or Diclofenac And Omeprazole For Gastrointestinal (GI) Safety In High GI Risk Patients With Arthritis [Phase 4]

View source ↗

Summary

Phase 4 study comparing celecoxib or diclofenac with omeprazole for GI safety in high GI risk arthritis patients, completed with posted results in 2010.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Arthritis Rheumatoid
• Osteoarthritis

Drugs mentioned

• Celecoxib (Celecoxib)
• Diclofenac (diclofenac)
• Omeprazole (Omeprazole)

Snippet

Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: Osteoarthritis, Arthritis, Rheumatoid | Phase 4 | Status: COMPLETED | Results posted: 2010-06-11